Search research articles
Contact Us
Filters
Showing results (1-10 of 361) with videos related to
Page
of 37
Sort By:
Cancers
|
February 26, 2025
Exploring the Potential of Adjuvant CDK4/6 Inhibitors in Hormone Receptor-Positive Early Breast Cancer: A Consistent Approach for All
Jianbin Li
Cancer Biology & Medicine
|
October 22, 2024
Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) Guidelines in 2024: International Contributions from China
Jianbin Li, Zefei Jiang
Scientific Reports
|
March 8, 2025
The impacts of technological overlap on international collaboration in China's green innovation endeavors
Jie Lin, Jianbin Li
Cancer
|
November 3, 2023
Antibody drug conjugates in breast cancer in China: Highlights, challenges, and prospects
Jianbin Li, Zefei Jiang
Heliyon
|
February 7, 2025
Impact of HER2-targeting antibody drug conjugates in treatment strategies for patients with breast cancer
Hanghang Ma, Jianbin Li
Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences
|
March 29, 2026
[Association of metabolic syndrome and its components with gout: an analysis based on a large-scale health survey database]
Jianbin Li, Wei Liu
Cancer Biology & Medicine
|
June 28, 2022
Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification
Jianbin Li, Zefei Jiang
Cancer Biology & Medicine
|
April 13, 2026
Artificial intelligence in breast cancer: applications and advancements
Jianbin Li, Zefei Jiang
Accounts of Chemical Research
|
September 9, 2025
Quinoline as a Photochemical Toolbox: From Substrate to Catalyst and Beyond
Jianbin Li, Chao-Jun Li
International Immunopharmacology
|
October 16, 2025
CASP1 as a potential target of Dendrobium in Sjögren's syndrome: Multi-omics analysis and preliminary experimental evidence
Jianbin Li, Renhe Li, Wei Liu
Page
of 37
Search research articles
Search
Showing results (1-10 of 361) with videos related to
Sort By:
Page
of 37
Cancers
|
February 26, 2025
Exploring the Potential of Adjuvant CDK4/6 Inhibitors in Hormone Receptor-Positive Early Breast Cancer: A Consistent Approach for All
Jianbin Li
Cancer Biology & Medicine
|
October 22, 2024
Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) Guidelines in 2024: International Contributions from China
Jianbin Li, Zefei Jiang
Scientific Reports
|
March 8, 2025
The impacts of technological overlap on international collaboration in China's green innovation endeavors
Jie Lin, Jianbin Li
Cancer
|
November 3, 2023
Antibody drug conjugates in breast cancer in China: Highlights, challenges, and prospects
Jianbin Li, Zefei Jiang
Heliyon
|
February 7, 2025
Impact of HER2-targeting antibody drug conjugates in treatment strategies for patients with breast cancer
Hanghang Ma, Jianbin Li
Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences
|
March 29, 2026
[Association of metabolic syndrome and its components with gout: an analysis based on a large-scale health survey database]
Jianbin Li, Wei Liu
Cancer Biology & Medicine
|
June 28, 2022
Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification
Jianbin Li, Zefei Jiang
Cancer Biology & Medicine
|
April 13, 2026
Artificial intelligence in breast cancer: applications and advancements
Jianbin Li, Zefei Jiang
Accounts of Chemical Research
|
September 9, 2025
Quinoline as a Photochemical Toolbox: From Substrate to Catalyst and Beyond
Jianbin Li, Chao-Jun Li
International Immunopharmacology
|
October 16, 2025
CASP1 as a potential target of Dendrobium in Sjögren's syndrome: Multi-omics analysis and preliminary experimental evidence
Jianbin Li, Renhe Li, Wei Liu
Page
of 37